Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.
about
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsRelationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failureAdherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysisIdentification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapyA randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomesDeterminants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapyMultiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan childrenAdherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort StudyWhich method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?Challenges in initiating antiretroviral therapy in 2010.A pandemic of the poor: social disadvantage and the U.S. HIV epidemic.Adaptation of an HIV Medication Adherence Intervention for Adolescents and Young AdultsMobile phone text messages for improving adherence to antiretroviral therapy (ART): a protocol for an individual patient data meta-analysis of randomised trials.Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials.Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa.Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or "How the 'Broken Window' Theory Pertains to ART Adherence".The adherence-outcome relationship is not altered by diary-driven adjustments of microelectronic monitor data."That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme.Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia.Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.Effect of a smartphone application incorporating personalized health-related imagery on adherence to antiretroviral therapy: a randomized clinical trial.The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option?Understanding the facilitators and barriers of antiretroviral adherence in Peru: a qualitative study.Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South AfricaSite nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384.Exploring 'generative mechanisms' of the antiretroviral adherence club intervention using the realist approach: a scoping review of research-based antiretroviral treatment adherence theories.Pilot study of a multi-pronged intervention using social norms and priming to improve adherence to antiretroviral therapy and retention in care among adults living with HIV in Tanzania.Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa.Patients' perspectives on informal caregiver involvement in HIV health care appointments.Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort studyPrevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS.Utilization of medical treatments and adherence to antiretroviral therapy among HIV-positive adults with histories of childhood sexual abuse.Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study.The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic populationUsing electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in ChinaClustering based on adherence data.
P2860
Q22241321-FFEF303B-C46A-48AB-86D6-8F9B82E904A0Q27003431-6532FE63-0F53-43CB-A07B-D47508CA5F31Q27024379-457907BA-A438-4647-A928-3BF0663DF098Q27318276-5BB24AEC-AFEF-49EE-B9B5-6B184656AD8CQ28472810-ED325A9B-D747-4193-A121-BCF9E588E32AQ28477310-F1BEBFE8-99E5-4ED2-B7D0-AE9544AD1109Q28478666-D35797CC-0AA7-469F-B141-7896E94C5246Q28483617-2734AC45-15E4-4EEA-8ED2-57CB1327D98CQ28534423-9833A6CC-8212-4888-A9E1-1E12F473D03DQ29353869-2DB0BD5F-51A6-48C3-952D-F60C599E8B86Q30227046-5955A36D-6686-4CD3-B7FB-B8938BB41291Q30430745-DDBFEB5A-1303-4B5F-BAB8-B21EAEA5B1FBQ30602862-C61D1A2D-490C-4ECA-AFFF-1A8FA7CA1771Q30651155-5F6346D2-4F51-42AD-9294-8F251D7C1D14Q30666487-DB07E9D5-51CE-4021-9A29-355D7A7CB90DQ30717222-EA700D84-5749-43AB-AADB-48D2241233FBQ30843756-8FD334E6-D25A-45B6-ABCA-9BA0D7AFB320Q30936928-6ABDD38A-C398-46D0-9A97-132472F1B4DDQ31004361-1CDF1980-BA59-4F9D-AE6C-9EA477F815A4Q33320220-42870B51-259A-4C57-B3BF-5F0C5A0502ADQ33336597-B551EA82-119B-4A82-9A07-624E0BC4535FQ33355997-A7EA70F7-B5A9-4A03-B4B3-EB52A80C2D3AQ33441775-B9F923A5-6DA5-4B82-A0DC-636F2A3A617BQ33507274-03D52839-1B61-4D8C-A57B-01D1C128C877Q33520008-C9F8587E-8319-453C-A8D8-53E993B4B529Q33523621-3AB6DA49-B9FA-43D8-8782-BDF80D4A635EQ33532759-5DB58206-9C7D-4907-BE1E-2CA50121B1E8Q33537373-58C92A9C-D226-40F6-A143-E71825C79CE0Q33602445-F96B2E2B-ADC9-4462-B3E4-7C9DF79903F3Q33640410-FBF4B20E-FFD0-47A7-BFA8-F3608FDF4A12Q33653200-B831F74E-C6B8-4407-AB65-5229F9F225FCQ33694858-D383F62D-8C50-4F8A-965D-9754E78F4893Q33705650-B2BBC90E-2C6C-4C5E-820D-21FC11D23EF2Q33737751-EB8334B1-CD12-4C88-A0FE-F315754CEED4Q33796930-3E87FE7D-5B20-4919-84D6-B3FF825C12BFQ33796937-F789DAD4-D8BE-409E-9D13-0684299DF430Q33814942-CC706733-2913-4E42-8350-E67FD9CAF804Q33827836-12E3D75E-14C7-47FD-A52C-4F976E9BF384Q33833865-FD90ED00-5D8C-4C6F-BAC3-EBAAA63FA520Q33840321-D0D328F3-4A21-488C-A367-A479A7E2AECB
P2860
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Less than 95% adherence to non ...... can lead to viral suppression.
@en
Less than 95% adherence to non ...... can lead to viral suppression.
@nl
type
label
Less than 95% adherence to non ...... can lead to viral suppression.
@en
Less than 95% adherence to non ...... can lead to viral suppression.
@nl
prefLabel
Less than 95% adherence to non ...... can lead to viral suppression.
@en
Less than 95% adherence to non ...... can lead to viral suppression.
@nl
P2860
P356
P1476
Less than 95% adherence to non ...... can lead to viral suppression.
@en
P2860
P304
P356
10.1086/507526
P407
P577
2006-08-23T00:00:00Z